V. Stepanenko et al. / Tetrahedron Letters 50 (2009) 995–998
997
Table 3
2. Ager, D. J. Handbook of Chiral Compounds; Marcel Dekker: New York, 1999. pp
211–225.
Reduction of representative chiral ketones using 1 mol % of aminoborate ester 1a
3. (a) Corey, E. J.; Helal, C. J. Angew.Chem., Int. Ed. 1998, 37, 1986–2012; (b) Deloux,
L.; Srebnik, M. Chem. Rev. 1993, 93, 763–784.
Entry
1e
Substrate
Yieldb (%)
eec (%)
Configurationd,14
4. (a) Cho, B. T. Tetrahedron 2006, 62, 7621–7643; (b) Glushkov, V. A.; Tolstikov, A.
G. Russ. Chem. Rev. 2004, 73, 581–608.
O
´
5. (a) Stepanenko, V.; Ortız-Marciales, M.; Correa, W.; De Jesús, M.; Espinosa, S.;
93
95
(R)
´
Ortız, L. Tetrahedron: Asymmetry 2006, 17, 112–115; (b) Stepanenko, V.; De
Jesús, M.; Correa, W.; Guzman, I.; Vázquez, C.; De la Cruz, W.; Ortiz-Marciales,
M.; Barnes, C. L. Tetrahedron Lett. 2007, 48, 5799–5802; (c) Stepanenko, V.; De
Jesús, M.; Correa, W.; Guzman, I.; Vázquez, C.; Ortiz, L.; Ortiz-Marciales, M.
Tetrahedron: Asymmetry 2007, 18, 2739–2745; (d) Ortiz-Marciales, M.;
Stepanenko, V.; Correa, W.; De Jesús, M.; Espinosa, S. U.S. Patent Application
11/512,599, August 30, 2006.
N
S
O
O
2
3
91
90
96
96
(R)
(R)
O
6. (a) Masui, M.; Shioiri, T. Synlett 1997, 273–274; (b) Masui, M.; Shioiri, T.
Tetrahedron 1995, 51, 8363–8370; (c) Masui, M.; Shioiri, T. Tetrahedron Lett.
1998, 39, 5195–5198.
7. (a) Xu, J.; Wei, T.; Zhang, Q. J. Org. Chem. 2003, 68, 10146–10151; (b) Xu, J.; Su,
X.; Zhang, Q. Tetrahedron: Asymmetry 2003, 2003, 1781–1786; (c) Xu, J.; Wei, T.;
Zhang, Q. J. Org. Chem. 2004, 69, 6860–6866; (d) Liu, H.; Xu, J. X. J. Mol. Catal. A:
Chem. 2006, 244, 68–72.
8. (a) Garrett, C. E.; Prasad, K.; Repie, O.; Blacklock, T. Tetrahedron: Asymmetry
2002, 13, 1347–1349; (b) Mathre, D. J.; Jones, T. K.; Xavier, L. C.; Blacklock, T. J.;
Reamer, R. A.; Mohan, J. J.; Turner Jones, E. T.; Hoogsteen, K.; Baum, M. W.;
Grabowski, E. J. J. J. Org. Chem. 1991, 56, 751–762; (c) Gnanadesikan, V.; Corey,
E. J. Org. Lett. 2006, 8, 4943–4945.
O
S
Cl
4
92
99
(R)
O
5
6
95
88
99
98
(R)
(S)
9. (a) Krzeminski, M. P.; Wojtczak, A. Tetrahedron Lett. 2005, 46, 8299–8302; (b)
Santhi, V.; Rao, J. M. Tetrahedron: Asymmetry 2000, 11, 3553–3560; (c) Ponzo, V.
L.; Kaufman, T. S. Synlett 2002, 1128–1130.
O2N
O
10. Preparation of (ꢀ)-(3aS)-1,1-dimethoxy-3,3-diphenyl-hexahydro-1H-pyrrolo[1,2-
Cl
c][1,3,2]oxazaborol-7-ium-1-uide (1): To a solution of (S)-diphenyl(pyrrolidin-2-
yl)methanol (2.53 g, 10.0 mmol) in dry isopropyl ether (25 mL)
a freshly
redistilled neat dimethyl borate (3 mL, 28.9 mmol) was added drop wise at
room temperature under nitrogen atmosphere. The resulting mixture was left
without stirring over 24 h (after 2 h white crystals started to grow). The
precipitate was filtered, washed with isopropyl ether (4 ꢁ 10 mL) under
nitrogen atmosphere and dried under vacuum at 60 °C over 12 h to give the
F
F
O
7
94
99
(R)
final product as a white solid (2.21 g, 68 % yield). Mp 132–136 °C. IR (m
, cmꢀ1):
3300 (NH), 3059, 2964, 1598, 1390, 1103, 1022; 1H NMR (400 MHz, CDCl3): d
(ppm) 1.42–1.66 (m, 4H, (CH2)2), 2.03–3.23 (m, 8H, B(OMe)2 and NCH2), 4.26–
4.31 (m, 1H, NCH), 6.37 (br d, J = 6.0 Hz, 1H, NH), 7.11–7.28 (m, 6H, CHAr), 7.46–
7.50 (m, 4H, CHAr); 13C NMR (100 MHz, CDCl3): d (ppm) 24.8, 29.0, 46.7, 49.6
(br, 2MeO), 81.4, 126.1, 126.2, 126.3, 126.5, 127.7, 127.8, 146.2, 147.8; 11B NMR
a
The reduction was carried out using 0.7 equiv of borane–DMS in THF at room
temperature.
b
c
Isolated yield after distillation in a Kugelrohr apparatus.
Determined by GC of acetate on chiral column.
Absolute configuration was determined by comparison of optical rotations with
(128 MHz, CDCl3): d 6.7 (s); ½a D23
ꢀ130 (c 1.3, CHCl3).
ꢂ
d
11. The crystal structure has been deposited at the Cambridge Crystallographic
Data Centre and allocated the deposition number CCDC CCDC 704941. Formula:
C19 H24 B N O3; Crystal size 0.55 ꢁ 0.35 ꢁ 0.30 mm. Crystal system, space
group monoclinic, P 21. Unit cell dimensions: a = 9.9641(5) Å alpha = 90 deg;
b = 18.7001(9) Å beta = 107.8240(10)deg; c = 10.1265(5) Å gamma = 90 deg.
Table hydrogen bonds with Hꢃ ꢃ ꢃA < r(A) + 3.200 Å and hDHAh110 deg:
literature values. The configuration of new optical active compounds was assigned
by analogy.
e
The reduction was carried out using 1.7 equiv of borane–DMS.
that the in situ prepared oxazaborolidine methods are more conve-
nient, these methods have been reported to provide less reproduc-
ible results,8a probably due to impurities present in the reaction
mixture and, therefore, require larger amounts of expensive cata-
lysts. Our process is more economical since it uses less diphenyl-
prolinol. Moreover, the less catalytic load permits an easier
purification process that is well suited to large scale syntheses.
In summary, we have prepared new dimethoxy(aminoalk-
oxy)borate catalysts, which were isolated and characterized. Amin-
oborate ester 1 was used for the highly enantioselective and
efficient borane reduction of variety aromatic ketones with only
1 mol % of catalytic loading. Moreover, the versatility of the meth-
od was studied using a variety of heterocyclic and aliphatic ketones
obtaining excellent yields of high enantiomerically enriched sec-
ondary alcohols, which are important in the synthesis of biologi-
cally active compounds.
D–H
d(D–H)
d(Hꢃ ꢃ ꢃA)
1.953
1.963
<DHA
d(Dꢃ ꢃ ꢃA)
2.810
2.858
A
N1A–H1NA
N1B–H1NB
0.882
0.911
163.93
167.05
O2B
O2A
12. Preparation of (it 4S,5R)-2, 2-dimethoxy-4-methyl-5-phenyl-1,3, 2-oxazaborolidin-
3-ium-2-uide (5): To a solution of (1R,2S)-norephedrine (1.51 g, 10.00 mmol) in
dry diethyl ether (25 mL),
a freshly redistilled neat methyl borate (3 mL,
28.88 mmol) was added drop wise over 1 min at 25 °C under a nitrogen
atmosphere. During the addition a white precipitate was formed. The resulting
mixture was stirred over 12 h at 25 °C. The precipitate was filtered, washed with
diethyl ether (5 ꢁ 10 mL) under nitrogen atmosphere and dried under vacuum to
give final product as a white crystalline solid (1.70 g, 76% yield). Mp: 127–130 °C.
IR (m
, cmꢀ1): 3225, 3083, 1607, 1449, 1337, 1196, 1119, 1067; 1H NMR (400 MHz,
DMSO-d6): d (ppm) 1.66 (d, J = 6.8 Hz, 3H, CHMe), 3.21 (s, 6H, 2 OMe), 3.44–3.51
(m, 1H, NCH), 4.90 (d, J = 5.3 Hz, 1H, OCH), 5.46 (br s, 2H, NH2), 7.18–7.39 (m, 5H,
Ph); 13C NMR (100 MHz, DMSO-d 6): d 14.3, 48.6, 51.8, 126.0, 126.3, 127.7, 141.5;
11B-NMR (128 MHz, DMSO-d6): d (ppm) 6.5 (s); ½a 2D3
= ꢀ33° (c 4.3, DMSO). HRMS
ꢂ
m/z: 222.12766 found (calculated for C11H17O3N111B1, (MꢀH)+ requires
222.12960).
13. Reduction of 40-nitroacetophenone using 1 mol % of borate ester 1. Preparation of
(+)-(R)-1-(4-nitrophenyl) ethanol: Borane–SMe2 complex (10 M, 0.7 mL,
7.0 mmol) was added to a solution of catalyst 1 (32.5 mg, 0.10 mmol) in dry
THF (5 mL) at 25 °C and the mixture was stirred for 1 h. A solution of 40-
nitroacetophenone (1.65 g, 10.0 mmol) in THF (5 mL) was added for 1 h using
an infusion pump. The reaction mixture was stirred at rt over 1 h, then cooled
at 0 °C and quenched with methanol (3 mL). The reaction mixture was
concentrated, washed with water (50 mL) and the product was extracted
with dichoromethane (3 ꢁ 20 mL). The extract was dried over Na2SO4 and
concentrated; the residue was distilled in a Kugelrohr apparatus under vacuum
to give the final product as a yellow oil (1.59 g, 95%). 1H NMR (400 MHz, CDCl3):
d (ppm) 1.51 (d, J = 6.8 Hz, 3H, Me), 2.44 (br s, 1H, OH), 5.01 (q, J = 6.5 Hz,
CHMe), 7.52–7.55 (m, 2H, CHAr), 8.16–8.19 (m, 2H, CHAr); 13C NMR (100 MHz,
CDCl3): d(ppm) 25.5, 69.5, 123.7, 126.2, 147.2, 153.2. The enantiomeric excees
Acknowledgements
We thank NIH for the financial support through their MBRS
(GM 08216), INBRE (NC P20 RR-016470) and NSF-ADVANCE
(SBE-0123645).
References and notes
1. (a) Shinkai, I. Pure Appl. Chem. 1997, 69(3), 453–458; (b) Reductions in Organic
Synthesis; Abdel-Magid, A. F., Ed.; American Chemical Society: Washington, DC,
1996; Vol. 641.